This study is looking at tumor tissue from people with lung and other chest (thoracic) cancers. Researchers want to understand how these cancers respond to treatments that target specific cancer genes (oncogene-targeted therapies). They will analyze tissue samples to find changes in the cancer cells both before and during treatment. This helps them learn why some treatments work and why some cancers become resistant. You may be able to join if you are 18 to 85 years old, have a thoracic cancer, and are receiving or being evaluated for oncogene-targeted therapies. The goal is to see if this information can help doctors choose better treatments for patients. The study is currently unclear on its recruitment status.

Study design

This is an observational study planning to include 500 participants. It aims to identify changes in tumor tissue.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint will be measured at a time to be determined upon funding.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.